Metal-Organic Frameworks (MOFs) Global Market Report 2025-2035, with Detailed Profiles of 45+ Active Companies in the MOF Space, Including Start-ups, Established Manufacturers, and End-users – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Market for Metal-Organic Frameworks (MOFs) 2025-2035” report has been added to ResearchAndMarkets.com’s offering. Metal-organic frameworks (MOFs) represent one of the most promising classes of advanced materials developed in recent decades, characterized by their tunable porous structures, exceptional surface areas, and customizable chemical functionalities. Despite over 100,000 MOF structures having been synthesized in … [Read more…]

Trilobio Raises $8M to Deliver Whole Lab Automation for Biologists

  SAN FRANCISCO–(BUSINESS WIRE)–Trilobio, the Company building the fully automated robotic lab-in-a-box for biologists, today announced it has raised $8 million USD Seed investment. The oversubscribed round was led by Initialized Capital, including participation from Argon Ventures and Lowercarbon Capital. Trilobio was founded in 2021 to address the established data quality and reproducibility challenges limiting … [Read more…]

Bristol Myers Squibb Appoints Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer

Gallman’s Appointment is Effective Immediately Sandra Leung, Executive Vice President, General Counsel Retires After 33 Years of Service PRINCETON, N.J.–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE: BMY) today announced the appointment of Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer, effective immediately. Gallman succeeds Sandra (Sandy) Leung, who has chosen to retire after … [Read more…]

Ethris Receives €10 Million EU4Health Grant to Support Clinical Development and Expand Antiviral Applications of Lead mRNA Candidate ETH47

ETH47 is a first-in-class mRNA antiviral therapy with broad-spectrum potential The project will generate key preclinical and clinical data to validate ETH47’s potential in combating a broad range of respiratory and systemic infections and via several routes of administration MUNICH–(BUSINESS WIRE)–Ethris GmbH, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics and vaccines, today announced that … [Read more…]

Innate Pharma announces conference call and webcast for Q1 2025 business update

MARSEILLE, France–(BUSINESS WIRE)–#innatepharma–Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), today announced that the Company will hold a conference call on Tuesday, May 13, 2025, at 2 p.m. CEST / 8 a.m. EDT, to give an update on business progress during the first quarter of 2025. In addition, members … [Read more…]

AGC Biologics Partners with Novelty Nobility for Cell Line Development and Phase I Preparations of Antibody Drug Candidate

Global CDMO supports South Korean company on a multiphase project at its Copenhagen and Chiba sites COPENHAGEN, Denmark & CHIBA, Japan–(BUSINESS WIRE)–AGC Biologics, your friendly CDMO expert, today announced a multiphase partnership with Novelty Nobility Inc., a clinical-stage biotech company based in South Korea. Novelty Nobility will leverage AGC Biologics’ expertise and proprietary CHEF1® expression … [Read more…]

Thetis Pharmaceuticals Presents New Preclinical and Clinical Data forTP-317 at DDW 2025

Findings Highlight First-in-Class Potential of TP-317 in Inflammatory Bowel Disease and Colorectal Cancer ESSEX, Conn.–(BUSINESS WIRE)–#IBD–Thetis Pharmaceuticals LLC (“Thetis”), a clinical-stage company developing TP-317, a first-in-class, small molecule drug candidate targeting the BLT1 receptor to treat inflammatory bowel disease (IBD) and solid tumor cancers, today announced the presentation of four data sets at Digestive Disease … [Read more…]

Vertex Reports First Quarter 2025 Financial Results

— Total revenue of $2.77 billion, a 3% increase compared to Q1 2024; raised the low end of total revenue guidance by $100 million to a new range of $11.85 to $12 billion — — Strong progress with CASGEVY®, ALYFTREK™ and JOURNAVX™ launches — — Povetacicept (pove) IgAN Phase 3 interim analysis (IA) cohort fully … [Read more…]

ABBYY Positioned a Leader for the 7th Time in Everest Group’s Intelligent Document Processing (IDP) Products PEAK Matrix® Assessment 2025

AUSTIN, Texas–(BUSINESS WIRE)–#AI–For the seventh year in a row, ABBYY is recognized as a Leader in Everest Group’s Intelligent Document Processing (IDP) and Banking and Financial Services (BFS)-specific IDP Products PEAK Matrix® Assessment 2025. With businesses facing increasing pressure to reliably automate document-centric processes to reduce costs and improve efficiency, the IDP Products PEAK Matrix® … [Read more…]

Andau Medical Announces the North American Launch of the World’s First Multi-Magnification Ergo Loupe

EDMONTON, Alberta–(BUSINESS WIRE)–#andau—Andau Medical, a leading provider of innovative medical and dental technologies, is proud to announce the North American launch of the Ergo V and Ergo V Pro loupes, the world’s first multi-mag ergo loupes. Manufactured by Admetec and distributed in North America by Andau Medical, these groundbreaking products are designed to enhance clinical … [Read more…]